The Kong Lab for Cardiovascular Biomaterials and Tissue Engineering is a multidisciplinary academic research laboratory specialising in biomaterial design, fabrication, and evaluation for cardiovascular disease treatment. We also pursue tissue engineering research, including the construction of artificial tissues, organs, and scaffolds to induce tissue regeneration. A major focus is on tackling vascular problems in regenerative medicine, using artificial blood vessels, bioactive hydrogels, stem cell-inspired therapeutics, nanomaterials, and other strategies to promote the angiogenesis and repair of damaged tissues.

The laboratory has currently operates a National Key Research and Development Program and several National Natural Science Foundation of China projects. The lab PI, Prof. Kong, has published more than 450 SCI papers, cited more than 29,500 times with a h-index of 90 (i10-index, 383). The Kong Lab has been involved in obtaining authorization of over 45 invention patents; has accomplished 1x first prize and 1x second prize from the Tianjin Natural Science Foundation, and participated in achieving 1x second prize of the National Science and Technology Progress Award, 1x first prize of Tianjin Natural Science Foundation, 1x second prize of the Tianjin Science and Technology Progress Award, among other accolades. The Kong Lab won the gold medal for the doctoral student team of the Shensuo Project - and developed the World's first innovative first-generation neural catheter for the 5th China Internet+ Innovation and Entrepreneurship Competition for College Students. In addition, the Kong Lab's artifical blood vessels have entered clinical trials.

Our Main Research Themes include:

Small Diameter Artifical Vascular Grafts

Stem Cell Based Therapies for Ischemic Diseases

Multifunctional Biomaterials for Tissue Regeneration

Vascularized organoid construction and application

A pro-regenerative multi-organ perfusion reactor platform